07:00 , Sep 2, 2013 |  BC Week In Review  |  Clinical News

Avioq HTLV-I/II Microelisa System regulatory update

Avioq said Health Canada approved in July its Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in serum or plasma. The enzyme-linked immunosorbent assay...
07:00 , Apr 22, 2013 |  BC Week In Review  |  Company News

Avioq sales and marketing update

Avioq launched the Avioq HTLV-I/II test in the EU and countries that recognize CE Mark to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in serum or plasma. The...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Clinical News

Avioq HTLV-I/II Microelisa System regulatory update

FDA approved Avioq's Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in blood and blood components. The enzyme-linked immunosorbent assay (ELISA) may be used...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Clinical News

Avioq HIV-1 Microelisa System regulatory update

FDA approved a PMA from Avioq for Avioq HIV-1 Microelisa System to detect HIV-1 antibodies in human serum, plasma, dried blood spots or oral fluid specimens. The assay can detect antibodies in oral fluid specimens...